Skip to main content

Table 2 Laboratory data at diagnosis

From: Clinical analysis of chronic active EBV infection with coronary artery dilatation and a matched case–control study

Pt WBC (× 109/L) Hb (g/L) PLT (× 109/L) ALT (U/L) AST (U/L) CK-MB (U/L) EBV-DNA (whole blood) (Copies/mL) EBV-DNA (plasma) (Copies/mL) sCD25 (ng/L) SF (ug/L) IL-6 (ng/L) IL-10 (ng/L) TNF-α (ng/L)
1 2.45 108 144 1928.0 1806.0 24 1.56 × 107 5.00 × 103 1830.0 216.0 13.95 7.06 6.57
2 6.01 121 137 524.0 584.1 20 1.60 × 107 2.94 × 104 8922.0 296.8 14.53 6.03 1.16
3 1.49 73 56 240.2 108.0 32 6.37 × 106 6.75 × 103 4574.0 89.3 12.45 10.15 2.59
4 6.41 122 422 68.9 141.6 22 7.70 × 106 2.08 × 103 1504.0 108.6 143.85 2.60 113.62
5 2.57 102 201 464.8 331.8 32 3.50 × 105 3.17 × 103 2541.0 509.4 11.77 3.23 0.00
6 7.87 98 118 221.2 368.5 14 1.15 × 107 3.77 × 105 23,684.0 888.0 19.44 18.00 3.60
7 5.19 111 137 38.4 26.2 19 1.9 × 105 1.30 × 105 3847.6 64.7 2500.00 1.79 525.62
8 9.91 131 270 22.8 12.2 10 3.96 × 107 1.54 × 103 3849.2 27.8 6.46 3.22 0.31
9 4.52 94 110 37.1 29.4 18 1.20 × 107 5.17 × 104 2987.0 67.5 4.98 4.25 2.73
10 4.87 104 30 876.0 103.4 33 1.44 × 107 1.76 × 106 8519.0 91,893.2 76.98 270.01 0.71
  1. Pt patient, WBC white blood cell, Hb hemoglobin, PLT platelet, ALT alanine transaminase, AST aspartate transaminase, CK-MB creatine kinase MB, EBV Epstein–Barr virus, CA capsid antigen, EA early antigen, NA nuclear antigen